• 中国中文核心期刊
  • 中国科学引文数据库核心期刊
  • 中国科技核心期刊
  • 中国高校百佳科技期刊
高级检索

基于DNA的纳米材料在肿瘤治疗领域的研究进展

陈烨, 尹骏, 姚文兵, 高向东

陈烨, 尹骏, 姚文兵, 高向东. 基于DNA的纳米材料在肿瘤治疗领域的研究进展[J]. 中国药科大学学报, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
引用本文: 陈烨, 尹骏, 姚文兵, 高向东. 基于DNA的纳米材料在肿瘤治疗领域的研究进展[J]. 中国药科大学学报, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
CHEN Ye, YIN Jun, YAO Wenbing, GAO Xiangdong. Advances of DNA-based nanomaterials in tumor therapy[J]. Journal of China Pharmaceutical University, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
Citation: CHEN Ye, YIN Jun, YAO Wenbing, GAO Xiangdong. Advances of DNA-based nanomaterials in tumor therapy[J]. Journal of China Pharmaceutical University, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404

基于DNA的纳米材料在肿瘤治疗领域的研究进展

基金项目: “双一流”学科创新团队资助项目(No.CPU2018GF08)

Advances of DNA-based nanomaterials in tumor therapy

Funds: This study was supported by the Innovation Team of the “Double-First Class” Disciplines (No.CPU2018GF08)
  • 摘要: 肿瘤治疗药物通常存在水溶性差、靶向性低、稳定性差、不易被肿瘤细胞摄取等不足,开发一种理想的药物递送载体仍是肿瘤治疗领域亟待解决的重要问题。由于具有良好的序列可编程性、生物相容性和生物可降解性,基于DNA的纳米材料已被广泛用作肿瘤治疗的药物递送载体。大量研究表明,DNA纳米材料可以有效装载肿瘤治疗药物,实现肿瘤组织靶向递送、高效细胞摄取与刺激响应性药物释放。本文从DNA纳米技术的历史与发展入手,例举DNA纳米材料作为药物递送载体在化疗、基因治疗、免疫治疗和光动力疗法中的应用进展,并对其未来发展进行展望,以期为该领域其他研究工作者提供参考。
    Abstract: Antitumor drugs usually have deficiencies such as poor water solubility, low targeting, poor stability, and difficulty in being taken up by tumor cells. The development of an ideal drug delivery vehicle is still an urgent problem to be solved in the field of cancer therapy. Due to their excellent sequence programmability, biocompatibility and biodegradability, DNA-based nanomaterials have been widely used as drug delivery vehicles for cancer treatment. Numerous studies have shown that DNA nanomaterials can effectively load cancer therapeutic agents, and achieve tumor targeted delivery, efficient cellular internalization as well as stimuli-responsive drug release. Starting from the history and development of DNA nanotechnology, this review illustrates the application progress of DNA nanomaterial as drug delivery vehicle in chemotherapy, gene therapy, immunotherapy and photodynamic therapy, and the future development is prospected so as to provide some reference for other researchers in this field.
  • [1] Mohammad IS, He W, Yin L. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR[J]. Biomed Pharmacother, 2018, 100: 335-348.
    [2] Liu J, Zhang Y, Zeng Q, et al. Delivery of RIPK4 small interfering RNA for bladder cancer therapy using natural halloysite nanotubes[J]. Sci Adv, 2019, 5(9): eaaw6499.
    [3] Bhaskaran V, Yao Y, Bei F, et al. Engineering, delivery, and biological validation of artificial microRNA clusters for gene therapy applications[J]. Nat Protoc, 2019, 14(12): 3538-3553.
    [4] Xu J, Sun J, Ho PY, et al. Creatine based polymer for codelivery of bioengineered microRNA and chemodrugs against breast cancer lung metastasis[J]. Biomaterials, 2019, 210: 25-40.
    [5] Chen L, Zhou L, Wang C, et al. Tumor-targeted drug and CpG delivery system for phototherapy and docetaxel-enhanced immunotherapy with polarization toward M1-type macrophages on triple negative breast cancers[J]. Adv Mater, 2019, 31(52): e1904997.
    [6] Mirza Z, Karim S. Nanoparticles-based drug delivery and gene therapy for breast cancer: recent advancements and future challenges[J]. Semin Cancer Biol, 2019. doi:10.1016/j.semcancer. 2019. 10. 020.
    [7] Zhao H, Zhao B, Wu L, et al. Amplified cancer immunotherapy of a surface-engineered antigenic microparticle vaccine by synergistically modulating tumor microenvironment[J]. ACS Nano, 2019, 13(11): 12553-12566.
    [8] Liu JN, Bu W, Shi J. Chemical design and synthesis of functionalized probes for imaging and treating tumor hypoxia[J]. Chem Rev, 2017, 117(9): 6160-6224.
    [9] Seeman NC. Nucleic acid junctions and lattices[J]. J Theor Biol, 1982, 99(2): 237-247.
    [10] Zuo H, Mao C. A minimalist's approach for DNA nanoconstructions[J]. Adv Drug Deliv Rev, 2019, 147: 22-28.
    [11] Mohsen MG, Kool ET. The discovery of rolling circle amplification and rolling circle transcription[J]. Acc Chem Res, 2016, 49(11): 2540-2550.
    [12] Hong CA, Jang B, Jeong EH, et al. Self-assembled DNA nanostructures prepared by rolling circle amplification for the delivery of siRNA conjugates[J]. Chem Commun (Camb), 2014, 50(86): 13049-13051.
    [13] Yata T, Takahashi Y, Tan M, et al. Efficient amplification of self-gelling polypod-like structured DNA by rolling circle amplification and enzymatic digestion[J]. Sci Rep, 2015, 5: 14979.
    [14] Rothemund PW. Folding DNA to create nanoscale shapes and patterns[J]. Nature, 2006, 440(7082): 297-302.
    [15] Wei B, Dai M, Yin P. Complex shapes self-assembled from single-stranded DNA tiles[J]. Nature, 2012, 485(7400): 623-626.
    [16] Seeman NC. DNA in a material world[J]. Nature, 2003, 421(6921): 427-431.
    [17] Ouyang C, Zhang S, Xue C, et al. Precision-guided missile-like DNA nanostructure containing warhead and guidance control for aptamer-based targeted drug delivery into cancer cells in vitro and in vivo[J]. J Am Chem Soc, 2020, 142(3): 1265-1277.
    [18] Di Z, Zhao J, Chu H, et al. An acidic-microenvironment-driven DNA nanomachine enables specific ATP imaging in the extracellular milieu of tumor[J]. Adv Mater, 2019, 31(33): e1901885.
    [19] Dutta PK, Zhang Y, Blanchard AT, et al. Programmable multivalent DNA-origami tension probes for reporting cellular traction forces[J]. Nano Lett, 2018, 18(8): 4803-4811.
    [20] Liu Z, Pei H, Zhang L, et al. Mitochondria-targeted DNA nanoprobe for real-time imaging and simultaneous quantification of Ca2+ and pH in neurons[J]. ACS Nano, 2018, 12(12): 12357-12368.
    [21] Setyawati MI, Kutty RV, Leong DT. DNA nanostructures carrying stoichiometrically definable antibodies[J]. Small, 2016, 12(40): 5601-5611.
    [22] Wu SY, Chou HY, Yuh CH, et al. Radiation-sensitive dendrimer-based drug delivery system[J]. Adv Sci (Weinh), 2018, 5(2): 1700339.
    [23] Ge Z, Guo L, Wu G, et al. DNA origami-enabled engineering of ligand-drug conjugates for targeted drug delivery[J]. Small, 2020, 16(16): e1904857.
    [24] Liu J, Song L, Liu S, et al. A tailored DNA nanoplatform for synergistic RNAi-/chemotherapy of multidrug-resistant tumors[J]. Angew Chem Int Ed Engl, 2018, 57(47): 15486-15490.
    [25] Zhao H, Yuan X, Yu J, et al. Magnesium-stabilized multifunctional DNA nanoparticles for tumor-targeted and pH-responsive drug delivery[J]. ACS Appl Mater Interfaces, 2018, 10(18): 15418-15427.
    [26] Liu J, Song L, Liu S, et al. A DNA-based nanocarrier for efficient gene delivery and combined cancer therapy[J]. Nano Lett, 2018, 18(6): 3328-3334.
    [27] Jiang Q, Song C, Nangreave J, et al. DNA origami as a carrier for circumvention of drug resistance[J]. J Am Chem Soc, 2012, 134(32): 13396-13403.
    [28] Zhang Q, Jiang Q, Li N, et al. DNA origami as an in vivo drug delivery vehicle for cancer therapy[J]. ACS Nano, 2014, 8(7): 6633-6643.
    [29] Zhang H, Ma Y, Xie Y, et al. A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery[J]. Sci Rep, 2015, 5: 10099.
    [30] Yao C, Yuan Y, Yang D. Magnetic DNA nanogels for targeting delivery and multistimuli-triggered release of anticancer drugs[J]. ACS Applied Bio Materials, 2018, 1(6): 2012-2020.
    [31] Ma Y, Wang Z, Ma Y, et al. A telomerase-responsive DNA icosahedron for precise delivery of platinum nanodrugs to cisplatin-resistant cancer[J]. Angew Chem Int Ed Engl, 2018, 57(19): 5389-5393.
    [32] Wu T, Liu J, Liu M, et al. A nanobody-conjugated DNA nanoplatform for targeted platinum-drug delivery[J]. Angew Chem Int Ed Engl, 2019, 58(40): 14224-14228.
    [33] Liu J, Wu T, Lu X, et al. A self-assembled platform based on branched DNA for sgRNA/Cas9/antisense delivery[J]. J Am Chem Soc, 2019, 141(48): 19032-19037.
    [34] Wen AM, Steinmetz NF. Design of virus-based nanomaterials for medicine, biotechnology, and energy[J]. Chem Soc Rev, 2016, 45(15): 4074-4126.
    [35] Lee H, Lytton-Jean AK, Chen Y, et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery[J]. Nat Nanotechnol, 2012, 7(6): 389-393.
    [36] Roh YH, Lee JB, Shopsowitz KE, et al. Layer-by-layer assembled antisense DNA microsponge particles for efficient delivery of cancer therapeutics[J]. ACS Nano, 2014, 8(10): 9767-9780.
    [37] Chen G, Liu D, He C, et al. Enzymatic synthesis of periodic DNA nanoribbons for intracellular pH sensing and gene silencing[J]. J Am Chem Soc, 2015, 137(11): 3844-3851.
    [38] Hu Q, Li H, Wang L, et al. DNA nanotechnology-enabled drug delivery systems[J]. Chem Rev, 2019, 119(10): 6459-6506.
    [39] Rattanakiat S, Nishikawa M, Funabashi H, et al. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its effect on immunostimulatory activity[J]. Biomaterials, 2009, 30(29): 5701-5706.
    [40] Qu Y, Yang J, Zhan P, et al. Self-assembled DNA dendrimer nanoparticle for efficient delivery of immunostimulatory CpG motifs[J]. ACS Appl Mater Interfaces, 2017, 9(24): 20324-20329.
    [41] Li J, Pei H, Zhu B, et al. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides[J]. ACS Nano, 2011, 5(11): 8783-8789.
    [42] Ouyang X, Li J, Liu H, et al. Rolling circle amplification-based DNA origami nanostructrures for intracellular delivery of immunostimulatory drugs[J]. Small, 2013, 9(18): 3082-3087.
    [43] Schuller VJ, Heidegger S, Sandholzer N, et al. Cellular immunostimulation by CpG-sequence-coated DNA origami structures[J]. ACS Nano, 2011, 5(12): 9696-9702.
    [44] Wang C, Sun W, Wright G, et al. Inflammation-triggered cancer immunotherapy by programmed delivery of CpG and anti-PD1 antibody[J]. Adv Mater, 2016, 28(40): 8912-8920.
    [45] Zhuang X, Ma X, Xue X, et al. A photosensitizer-loaded DNA origami nanosystem for photodynamic therapy[J]. ACS Nano, 2016, 10(3): 3486-3495.
    [46] Chang K, Tang Y, Fang X, et al. Incorporation of porphyrin to pi-conjugated backbone for polymer-dot-sensitized photodynamic therapy[J]. Biomacromolecules, 2016, 17(6): 2128-2136.
    [47] Park J, Jiang Q, Feng D, et al. Size-controlled synthesis of porphyrinic metal-organic framework and functionalization for targeted photodynamic therapy[J]. J Am Chem Soc, 2016, 138(10): 3518-3525.
    [48] Shieh YA, Yang SJ, Wei MF, et al. Aptamer-based tumor-targeted drug delivery for photodynamic therapy[J]. ACS Nano, 2010, 4(3): 1433-1442.
    [49] Yang Y, Zhu W, Feng L, et al. G-quadruplex-based nanoscale coordination polymers to modulate tumor hypoxia and achieve nuclear-targeted drug delivery for enhanced photodynamic therapy[J]. Nano Lett, 2018, 18(11): 6867-6875.
    [50] Auvinen H, Zhang H, Nonappa, et al. Protein coating of DNA nanostructures for enhanced stability and immunocompatibility[J]. Adv Healthc Mater, 2017, 6(18):1700692.
  • 期刊类型引用(8)

    1. 刘健弘,张欣橦,李颖娴,杨展,符艺,周瑜芳. 药物缓释体系的研究进展. 广东化工. 2024(15): 90-92+45 . 百度学术
    2. 郑丽君,刘玲,张向荣. 脂质体在乳品中的应用. 中国药剂学杂志(网络版). 2023(01): 34-48 . 百度学术
    3. 郭文娣,彭玉帅,许卉,陈华. 脂质体制剂制备工艺及质量控制研究进展. 药物分析杂志. 2023(01): 61-69 . 百度学术
    4. 柳宇红,姜宇,郝贵周,刘善奎. 挤出法制备卡巴他赛脂质体的工艺优化. 药学研究. 2023(04): 243-246+284 . 百度学术
    5. 吴灿,关延彬,贾永艳. 药剂学课程思政探索——以“脂质体”为例. 中国教育技术装备. 2023(18): 72-74 . 百度学术
    6. 毛欣亮,邓惠林,张浩,李吉平,蔡德富,樊丽,孙珈,岳丽玲,潘思文,温宪春. 共载紫草素和盐酸阿霉素pH敏感脂质体的制备及理化性质评价. 齐齐哈尔医学院学报. 2023(23): 2201-2207 . 百度学术
    7. 蔡成龙,闫雪生,于蓓蓓,孙丹丹. 透明质酸修饰茯苓皮总三萜脂质体制备与表征研究. 辽宁中医药大学学报. 2022(05): 50-55 . 百度学术
    8. 张艺,杭太俊,宋敏. 载药脂质体包封率测定方法的研究进展. 中国药科大学学报. 2021(02): 245-252 . 本站查看

    其他类型引用(12)

计量
  • 文章访问数:  311
  • HTML全文浏览量:  17
  • PDF下载量:  604
  • 被引次数: 20
出版历程
  • 收稿日期:  2020-04-22
  • 刊出日期:  2020-08-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭